Clinical Trial: Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Sponsor and Collaborators
University of Medicine and Dentistry New Jersey

Contact
Contact: Andrew N. de la Torre, MD
973-972-1258
delatoan@umdnj.edu


Continue Reading

Principal Investigator
Andrew N. de la Torre, MD University of Medicine and Dentistry New Jersey

ClinicalTrials.gov Identifier
NCT00949182